Kings⌬n Lin, MD, PhD
@LinKingson
Followers
180
Following
290
Media
6
Statuses
49
Incoming @HarvardRadOnc, @YaleMSTP; 2024 @ForbesUnder30 Healthcare; 2022 @PDSoros fellow; biotech entrepreneur; aspiring physician-scientist, and corgi owner.
New Haven, CT
Joined April 2022
Today has been one of the most exciting days of my life as I #matched at my first choice residency program 🤩. I’m beyond estatic to be joining the @HarvardRadOnc residency program @MassGenBrigham! So grateful to support from @YaleMSTP, @PDSoros, family, friends and mentors 🙏!!!
9
5
70
RT @cenmag: Researchers designed a molecule that kills brain cancer cells while giving healthy cells time to repair their DNA: https://t.co….
cen.acs.org
Chemical & Engineering News (C&EN): Keeping you up to date with the chemistry news that matters most. Published by the American Chemical Society.
0
21
0
RT @chulkimMD: Landscape of ADCs by Dr. LoRusso. 11 approved ADCs among 349 ADCs that have entered the clinic (148 discontinued). Developin….
0
70
0
RT @SciencNews: Academic Metabolism. #PhD #PhDlife #academics #AcademicChatter #AcademicTwitter #Postdocs #Research #Science .
0
60
0
Part 2 of the KL-50 story now out in @J_A_C_S ! 🔑takeaways: (1) rate of reactions with DNA currently underappreciated, (2) fine-tuning those rates decreases multiple off-target pathways and results in ⬇️toxicity, (3) chemotherapies ARE targeted therapies. Part 3 coming soon. 😉.
It’s out! Our follow-up study on KL50, a novel DNA modifier that exploits brain tumor DDR defects! Grateful for the opportunity to collaborate w/ the @HerzonLab on this exciting project. @LinKingson @YaleRadOnc @YaleCancer . @Yale_Ventures @modifibio .
0
4
16
It’s crazy seeing the Twitter storm around the recent article reporting concerns regarding the shelf pass rates at UCLA and its implications. Meanwhile medical students at Yale 😅… What are shelf exams lol😂? #YaleSystem
0
0
5
RT @NatRevDrugDisc: Interested in prodrugs? This review in the June issue analyses approved prodrugs and discusses trends in their developm….
0
70
0
In 2013, I began college as a First-Gen, Low-Income student. 11 years and 1️⃣Bachelor’s + 2️⃣Master’s+ 1️⃣PhD + 1️⃣MD = 5️⃣degrees later, I am now the first and second doctor in my family. I’m ready now to put all this education to work caring for patients and finding new treatments!
3
5
40
RT @euanashley: Exercise may be the single most potent medical intervention ever known. Its benefits in prevention outstrip any known drugs….
0
255
0
RT @PDSoros: A huge congrats to #PDSoros Fellow @LinKingson who matched into the Harvard Radiation Oncology Program at Mass General/Brigham….
0
1
0
RT @NaOHBartfield: Gotta be honest if youre choosing a phd program based on your odds of success in VENTURE CAPITAL ive got bad news for yo….
0
1
0
RT @PDSoros: Congrats to #PDSoros Fellow @LinKingson who is on the 2024 @Forbes #30under30 list! Kingson, the cofounder of Modifi Bioscienc….
0
2
0
Honored to be a member of this year's @Forbes #30Under30 list for Healthcare. I'm perpetually inspired by the passion and persistence of my peers in their respective fields! .So much progress has been made, but there's so much more left to be done! .
6
6
59
Amazing work @ScienceChow!!!.
Excited (and a bit nervous) to share my first study as senior author! @ericsongg and I took a deep dive into whether IFNg signaling gene mutations indeed confer resistance to immune checkpoint blockade (ICB). Letter in @Cancer_Cell:
1
0
3
RT @EricTopol: As of 10 November 2022, it is estimated that 94% of Americans have had Covid at least once, much of those infections in the….
0
346
0
RT @ChemDepths: Möbius aromaticity, the "how in the hell is this aromatic" type of aromaticity. (Submitted by @/MMakaryn) .
0
18
0
Awesome work!.
Mismatch repair-deficient (MMRd) cancers all have ⬆️high mutation burdens, so why do some patients not respond to immune checkpoint blockade (ICB)? We explored this in a follow-up to a phase 2 trial of aPD-1 (pembro) in MMRd endometrial cancer @CD_AACR :
1
0
4
Only 11 more days until the application deadline. I encourage all immigrants and children of immigrants to apply for the Paul and Daisy Soros Fellowship for New Americans. It's not only a $90,000 fellowship for graduate school, but rather a wonderful life-long community!.
Applicants: it’s the final stretch as we approach the Oct. 27th deadline! As you go over your essays, ask yourself: Have you been vulnerable and sincere? Have you imagined the future and your potential contributions as if everything will go *right* for you & your career?.
0
2
11